NCT07430566

Brief Summary

It is a comparative monocentric study with longitudinal follow-up at 6 months in adolescents aged between 11 years and 17 years inclusive admitted to complete hospitalization either for suicidal behaviors or for other psychiatric causes. The objective is to explore the experiences of hospitalized adolescents regarding hospitalization, as well as their perceptions of the factors involved in their remission and their experience of the traumatic event(s) if they have been exposed.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
13mo left

Started Mar 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Mar 2026Sep 2027

First Submitted

Initial submission to the registry

February 18, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 24, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

1 year

First QC Date

February 18, 2026

Last Update Submit

February 18, 2026

Conditions

Keywords

suicideadolescentpost-traumatic stress disorderneurodevelopmental disordersrésiliencebiomarqueurscomportements suicidaires

Outcome Measures

Primary Outcomes (1)

  • CPC Questionnaire child version

    This questionnaire evaluates the symptoms of PTSD and their frequency in children aged 7 to 18 years, following a traumatic event. Completion time is 15-20 minutes and the total score can range from 0 (no symptoms) to 84 (maximum symptoms) for symptom intensity and from 0 (no functional impact) to 24 (maximum functional impact) for functional impairment. The scale will be administered by a clinician (psychologist or psychiatrist for children and adolescents).

    Baseline

Secondary Outcomes (17)

  • CPC questionnaire parents version

    Baseline

  • Questionnaire Life Event Checklist (LEC-5)

    Baseline

  • Schedule for Affective Disorders and Schizophrenia for school-age children (KSADS) full-life version

    Baseline

  • Post-traumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    Baseline

  • Affective Reactivity Index (ARI)

    Baseline

  • +12 more secondary outcomes

Study Arms (2)

suicide group

ACTIVE COMPARATOR

adolescents aged between 11 years old and 17 years inclusive admitted to hospital for suicidal behaviors

Biological: Blood samplesGenetic: genetic analysisOther: Questionnaires and scales

non-suicidal group

ACTIVE COMPARATOR

aged between 11 years old and 17 years inclusive admitted to hospital for other psychiatric causes without a history of suicidal behavior

Biological: Blood samplesGenetic: genetic analysisOther: Questionnaires and scales

Interventions

Blood samplesBIOLOGICAL

A blood test will be carried out during the inclusion visit, on site, with collection of the time of completion, the last food samples and tobacco consumption. A 2.5 mL Paxgene® tube for whole blood RNA and a 5 mL dry tube for serum will be collected.

non-suicidal groupsuicide group

If consent for genetic analyses is obtained, a 4.5 mL EDTA tube to collect native DNA will be taken during the blood test

non-suicidal groupsuicide group

* Child Posttraumatic Checklist (CPC) * Life Event Checklist (LEC-5) * Posttraumatic CheckList-5 * K-SADS * Affective Reactivity Index (ARI) * Child Youth Resilience Measure * Adverse Childhood Experiences International Questionnaire (ACE-IQ) * Metacognitions Questionnaire (MCQ-A) * Cognitive Emotion Regulation Questionnaire (CERQ) * Adolescent Dissociative Experience Scale (A-DES) * Behavioral Rating Inventory of Executive Function Self-Report (BRIEF-2)

non-suicidal groupsuicide group

Eligibility Criteria

Age11 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 11 and 17 years inclusive
  • Admitted for full-time psychiatric hospitalization
  • Obtaining consent from at least one of the adolescent's legal representatives and the adolescent's personal assent
  • \- Reason for admission: suicidal behavior (suicide attempt)
  • \- Reason for admission: other psychiatric causes (including suicidal thoughts without suicide attempt and non-suicidal self-injurious behavior)

You may not qualify if:

  • \- Neither parent available to participate in the intervention
  • \- History of suicidal behavior prior to the current hospitalization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Suicidal IdeationBehaviorSuicideStress Disorders, Post-TraumaticNeurodevelopmental Disorders

Interventions

Blood Specimen CollectionGenetic TestingSurveys and QuestionnairesWeights and Measures

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsStress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesGenetic TechniquesGenetic ServicesHealth ServicesHealth Care Facilities Workforce and ServicesDiagnostic ServicesPreventive Health ServicesData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Comparative study, monocentric, longitudinal, with follow-up at 6 months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 18, 2026

First Posted

February 24, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

February 24, 2026

Record last verified: 2026-02